Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

A. Magnette; M. Chatelain; B. Chatelain; H. Ten Cate; F. Mullier

doi:10.1186/s12959-016-0123-z

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

A. Magnette, M. Chatelain, B. Chatelain, H. Ten Cate, F. Mullier^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	49
Journal	Thrombosis Journal
Volume	14
DOIs	https://doi.org/10.1186/s12959-016-0123-z
Publication status	Published - 12 Dec 2016

Keywords

Haemostasis assays
Pre-analytical phase
Coagulation assays
Recommendations
Dabigatran
Idarucizumab
Microparticles
Centrifugation

Access to Document

10.1186/s12959-016-0123-z

Cite this

@article{e05038dafee8411983c2fb96e08400cf,

title = "Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories",

keywords = "Haemostasis assays, Pre-analytical phase, Coagulation assays, Recommendations, Dabigatran, Idarucizumab, Microparticles, Centrifugation",

author = "A. Magnette and M. Chatelain and B. Chatelain and {Ten Cate}, H. and F. Mullier",

year = "2016",

month = dec,

day = "12",

doi = "10.1186/s12959-016-0123-z",

language = "English",

volume = "14",

journal = "Thrombosis Journal",

issn = "1477-9560",

publisher = "BioMed Central Ltd",

}

TY - JOUR

T1 - Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

AU - Magnette, A.

AU - Chatelain, M.

AU - Chatelain, B.

AU - Ten Cate, H.

AU - Mullier, F.

PY - 2016/12/12

Y1 - 2016/12/12

KW - Haemostasis assays

KW - Pre-analytical phase

KW - Coagulation assays

KW - Recommendations

KW - Dabigatran

KW - Idarucizumab

KW - Microparticles

KW - Centrifugation

U2 - 10.1186/s12959-016-0123-z

DO - 10.1186/s12959-016-0123-z

M3 - Article

C2 - 27999475

VL - 14

JO - Thrombosis Journal

JF - Thrombosis Journal

SN - 1477-9560

M1 - 49

ER -